e-learning
resources
Munich 2014
Monday, 08.09.2014
Diagnosis, imaging and surgery for thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer
S. Michaelides, A. Emmanouelidou, G. Bablekos, G. Ionas, H. Ellina, N. Maouni, I. Platanos (Athens, Greece)
Source:
International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Session:
Diagnosis, imaging and surgery for thoracic tumours
Session type:
Thematic Poster Session
Number:
2768
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Michaelides, A. Emmanouelidou, G. Bablekos, G. Ionas, H. Ellina, N. Maouni, I. Platanos (Athens, Greece). Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer. Eur Respir J 2014; 44: Suppl. 58, 2768
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Bronchoscopic semantics and diagnosis of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Added value of EUS-B to EBUS for lung cancer staging
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Subtyping agreement between small cyto-histological samples and surgical specimens in NSCLC patients
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Determinants of negative predictive value during EBUS-TBNA in diagnosis/staging of lung cancer
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Bronchoscopic dissection
Source: International Congress 2015 – Advances in therapeutic bronchoscopy
Year: 2015
Role of the EBUS-EUS-FNA combined approach by using single ultrasound bronchoscope for tissue diagnosis in mediastinal lymphadenopathy
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Variation in lung cancer diagnosis in England
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Systematic vs hit-and-run endosonographic staging of lung cancer
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
Assessment of
SHOX2
methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
Source: Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Year: 2013
Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016
Electrospray-mediated local chemotherapy of lung carcinoma in mice
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
EBUS in real life: Primary diagnosis and mediastinal staging
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis?
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
EBUS-TBNA for nodal restaging and relapse in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept